Mechanism Wellness Healthy HeartSupplements for heart health and cardiovascular support
Opportunity Pathways - GLP-1 Diabetes Treatment Drugs Market The GLP-1 diabetes treatment drugs market represents one of the most explosive pharmaceutical opportunities of the decade, with the market projected to surge from USD 6,556.5 million in 2025 to USD 62,543.2 million by 2035 at an extraordinary 25.3% CAGRa 9.5X expansion driven by the global diabetes epidemic, breakthrough efficacy data, and expanding therapeutic applications beyond glucose control to include weight management and cardiovascular protection
1,44 However, recent RCTs have called into question whether this has any effect on glycemic control
While DPP-IV is effective at cleaving proline bonds, it is an exopeptidase , meaning it can only snip amino acids from the external ends of the long protein chain
The absence of these endpoints limits the ability to determine whether observed changes in lean mass translate into clinically meaningful impairments